1 |
UMARI M, FALINI S, SEGAT M, et al. Anesthesia and fast-track in video-assisted thoracic surgery (VATS): from evidence to practice[J]. J Thorac Dis, 2018, 10(): S542-S554.
|
2 |
AL-MUFARREJ F, MARGOLIS M, TEMPESTA B, et al. From Jacobeaus to the da Vinci: thoracoscopic applications of the robot[J]. Surg Laparosc Endosc Percutan Tech, 2010, 20(1): 1-9.
|
3 |
KIM B R, YOON S H, LEE H J. Practical strategies for the prevention and management of chronic postsurgical pain[J].Korean J Pain,2023,36(2): 149-162.
|
4 |
JIN Y, MAO Y, CHEN D Y, et al. Thalamocortical circuits drive remifentanil-induced postoperative hyperalgesia[J]. J Clin Invest, 2022,132(24): e158742.
|
5 |
ZHOU J, QI F, HU Z Q, et al. Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα[J]. Eur J Pharmacol, 2020, 869: 172882.
|
6 |
ENGELHARDT T, ZAAROUR C, NASER B, et al. Intraoperative low-dose ketamine does not prevent a remifentanil-induced increase in morphine requirement after pediatric scoliosis surgery[J]. Anesth Analg, 2008, 107(4): 1170-1175.
|
7 |
MA M T, WANG Z J, WANG J, et al. Endomorphin analog exhibited superiority in alleviating neuropathic hyperalgesia via weak activation of NMDA receptors[J]. J Neurochem, 2020, 155(6): 662-678.
|
8 |
YANG Y P, MAHER D P, COHEN S P. Emerging concepts on the use of ketamine for chronic pain[J]. Expert Rev Clin Pharmacol, 2020, 13(2): 135-146.
|
9 |
LEI Y S, LIU H Y, XIA F, et al. Effects of esketamine on acute and chronic pain after thoracoscopy pulmonary surgery under general anesthesia: a multicenter-prospective, randomized, double-blind, and controlled trial[J]. Front Med, 2021, 8: 693594.
|
10 |
STARKE H, ZINNE N, LEFFLER A, et al. Developing a minimally-invasive anaesthesiological approach to non-intubated uniportal video-assisted thoracoscopic surgery in minor and major thoracic surgery[J]. J Thorac Dis, 2020, 12(12): 7202-7217.
|
11 |
SHOJAEE S, LEE H J. Thoracoscopy: medical versus surgical-in the management of pleural diseases[J]. J Thorac Dis, 2015, 7(): S339-S351.
|
12 |
SWARM R A, KARANIKOLAS M, KALAUOKALANI D. Pain treatment in the perioperative period [J]. Curr Probl Surg,2001,38(11): 845-920.
|
13 |
SHIN S W, CHO A R, LEE H J, et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery[J]. Br J Anaesth, 2010, 105(5): 661-667.
|
14 |
KWOK R F K, LIM J, CHAN M T V, et al. Preoperative ketamine improves postoperative analgesia after gynecologic laparoscopic surgery[J]. Anesth Analg, 2004, 98(4): 1044-1049.
|
15 |
RIVOSECCHI R M, RICE M J, SMITHBURGER P L, et al. An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia[J]. Expert Opin Drug Saf, 2014, 13(5): 587-603.
|
16 |
JOLY V, RICHEBE P, GUIGNARD B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine[J]. Anesthesiology, 2005, 103(1): 147-155.
|
17 |
KEHLET H, JENSEN T S, WOOLF C J. Persistent postsurgical pain: risk factors and prevention[J]. Lancet, 2006, 367(9522): 1618-1625.
|
18 |
HIMMELSEHER S, DURIEUX M E. Revising a dogma: ketamine for patients with neurological injury?[J]. Anesth Analg, 2005, 101(2): 524-534.
|
19 |
WANG Y T, WANG X L, FENG S T, et al. Novel rapid-acting glutamatergic modulators: targeting the synaptic plasticity in depression[J]. Pharmacol Res, 2021, 171: 105761.
|
20 |
ZHU M, XU S Q, JU X, et al. Effects of the different doses of esketamine on postoperative quality of recovery in patients undergoing modified radical mastectomy: a randomized, double-blind, controlled trial[J]. Drug Des Devel Ther, 2022, 16: 4291-4299.
|
21 |
NEUKIRCHEN M, KIENBAUM P. Sympathetic Nervous System Evaluation and Importance for Clinical General Anesthesia [J]. Anesthesiology, 2008,109(6): 1113-1131.
|
22 |
ORSOLINI L, SALVI V, VOLPE U. Craving and addictive potential of esketamine as side effects?[J]. Expert Opin Drug Saf, 2022, 21(6): 803-812.
|
23 |
NIKAYIN S, MURPHY E, KRYSTAL J H, et al. Long-term safety of ketamine and esketamine in treatment of depression[J]. Expert Opin Drug Saf, 2022, 21(6): 777-787.
|